Tau and tauopathies.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Brain Research Bulletin

• Publication date

  2016-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.brainresbull.2016.08.018PMID 27615390
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Physiological and Pathophysiological Implications of Synaptic Tau

  2017cited by this paper
• Tau imaging in the study of ageing, Alzheimer's disease, and other neurodegenerative conditions.

  2016cited by this paper
• Neuronal activity enhances tau propagation and tau pathology in vivo

  2016cited by this paper
• Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies

  2016cited by this paper
• Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

  2016cited by this paper
• Is Huntington's disease a tauopathy?

  2016cited by this paper
• An evolutionary roadmap to the microtubule-associated protein MAP Tau

  2016cited by this paper
• Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

  2016cited by this paper
• Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine

  2016cited by this paper
• The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer’s Disease

  2016cited by this paper
• BIN1 regulates BACE1 intracellular trafficking and amyloid-β production.

  2016cited by this paper
• Tau neurotoxicity and rescue in animal models of human Tauopathies.

  2016cited by this paper
• PT572. Advances in the Development of Tau PET Radiotracers and Their Clinical Applications

  2016cited by this paper
• Obesity, diabetes, and leptin resistance promote tau pathology in a mouse model of disease.

  2016cited by this paper
• Characteristics of Tau and Its Ligands in PET Imaging

  2016cited by this paper
• Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity.

  2016cited by this paper
• PET Imaging of Tau Deposition in the Aging Human Brain.

  2016cited by this paper
• Lamin Dysfunction Mediates Neurodegeneration in Tauopathies.

  2016cited by this paper
• Characterization of Neuronal Tau Protein as a Target of Extracellular Signal-regulated Kinase*

  2016cited by this paper
• Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees

  2016cited by this paper
• Precortical Phase of Alzheimer's Disease (AD)‐Related Tau Cytoskeletal Pathology

  2016cited by this paper
• Tau phosphorylation‐associated spine regression does not impair hippocampal‐dependent memory in hibernating golden hamsters

  2016cited by this paper
• Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti‐tau antibody AT8

  2016cited by this paper
• Advances in the development of tau PET radiotracers and their clinical applications.

  2016cited by this paper
• Connecting the dots between tau dysfunction and neurodegeneration.

  2015cited by this paper
• Frontotemporal lobar degeneration: old knowledge and new insight into the pathogenetic mechanisms of tau mutations

  2015cited by this paper
• Tau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease

  2015cited by this paper
• Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease.

  2015cited by this paper
• Rare variants in β-Amyloid precursor protein (APP) and Parkinson’s disease

  2015cited by this paper
• Downregulation of the microtubule associated protein Tau impairs process outgrowth and myelin basic protein mRNA transport in oligodendrocytes

  2015cited by this paper
• A Novel Tau Mutation in Exon 12, p.Q336H, Causes Hereditary Pick Disease

  2015cited by this paper
• NEUROPATHOLOGY OF NEURODEGENERATIVE DISEASES: A PRACTICAL GUIDE

  2015cited by this paper
• A Novel MAPT Mutation Causing Corticobasal Syndrome Led by Progressive Apraxia of Speech

  2015cited by this paper
• Tau stabilizes microtubules by binding at the interface between tubulin heterodimers

  2015cited by this paper
• Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer’s disease or corticobasal degeneration brains

  2015cited by this paper
• PART, a distinct tauopathy, different from classical sporadic Alzheimer disease

  2015cited by this paper
• Tau Phosphorylation at Serine 396 Residue Is Required for Hippocampal LTD

  2015cited by this paper
• On the identification of low allele frequency mosaic mutations in the brains of Alzheimer's disease patients

  2015cited by this paper
• Alzheimer’s and Parkinson’s diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein

  2015cited by this paper
• Thr175-phosphorylated tau induces pathologic fibril formation via GSK3β-mediated phosphorylation of Thr231 in vitro.

  2015cited by this paper
• Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice.

  2015cited by this paper
• Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy

  2015cited by this paper
• Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case‐control study

  2015cited by this paper
• A novel tau mutation, p.K317N, causes globular glial tauopathy

  2015cited by this paper
• Folding of the Tau Protein on Microtubules.

  2015cited by this paper
• Invited review: Neuropathology of tauopathies: principles and practice

  2015cited by this paper
• Heroin abuse exaggerates age-related deposition of hyperphosphorylated tau and p62-positive inclusions.

  2015cited by this paper
• Inhibitor-1 and -2 of PP2A have preference between PP2A complexes.

  2015cited by this paper
• Mutant huntingtin alters Tau phosphorylation and subcellular distribution.

  2015cited by this paper
• Tau-mediated synaptic damage in Alzheimer’s disease

  2015cited by this paper
• The role of tau in the pathological process and clinical expression of Huntington’s disease

  2015cited by this paper
• Amyloid Precursor Protein (APP) Metabolites APP Intracellular Fragment (AICD), Aβ42, and Tau in Nuclear Roles*

  2015cited by this paper
• Pre‐synaptic C‐terminal truncated tau is released from cortical synapses in Alzheimer's disease

  2015cited by this paper
• Rapid alteration of protein phosphorylation during postmortem: implication in the study of protein phosphorylation

  2015cited by this paper
• The FK506‐binding protein FKBP52 in vitro induces aggregation of truncated Tau forms with prion‐like behavior

  2015cited by this paper
• Familial Behavioral Variant Frontotemporal Dementia Associated With Astrocyte-Predominant Tauopathy

  2015cited by this paper
• Pro-aggregant Tau impairs mossy fiber plasticity due to structural changes and Ca++ dysregulation

  2015cited by this paper
• The preclinical phase of the pathological process underlying sporadic Alzheimer's disease.

  2015cited by this paper
• Glial Tau Pathology in Tauopathies: Functional Consequences

  2015cited by this paper
• Intrinsically disordered proteins and their (disordered) proteomes in neurodegenerative disorders

  2015cited by this paper
• Tau imaging: early progress and future directions.

  2015cited by this paper
• Early neurone loss in Alzheimer’s disease: cortical or subcortical?

  2015cited by this paper
• Depletion of microglia and inhibition of exosome synthesis halt tau propagation

  2015cited by this paper
• Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.

  2015cited by this paper
• Closing the tau loop: the missing tau mutation.

  2015cited by this paper
• Pseudophosphorylation of Tau at distinct epitopes or the presence of the P301L mutation targets the microtubule-associated protein Tau to dendritic spines.

  2015cited by this paper
• Regional mosaic genomic heterogeneity in the elderly and in Alzheimer’s disease as a correlate of neuronal vulnerability

  2015cited by this paper
• Nuclear magnetic resonance spectroscopy characterization of interaction of Tau with DNA and its regulation by phosphorylation.

  2015cited by this paper
• The case for rejecting the amyloid cascade hypothesis

  2015cited by this paper
• Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?

  2015cited by this paper
• Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy

  2015cited by this paper
• Genetic Disorders with Tau Pathology: A Review of the Literature and Report of Two Patients with Tauopathy and Positive Family Histories

  2015cited by this paper
• Tau phosphorylation regulates the interaction between BIN1’s SH3 domain and Tau’s proline-rich domain

  2015cited by this paper
• Analysis of protein-coding genetic variation in 60,706 humans

  2015cited by this paper
• Beta-amyloid deposition in chronic traumatic encephalopathy

  2015cited by this paper
• PART is part of Alzheimer disease

  2015cited by this paper
• Human secreted tau increases amyloid-beta production.

  2015cited by this paper
• Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau

  2015cited by this paper
• Spreading of pathology in neurodegenerative diseases: a focus on human studies

  2015cited by this paper
• Three sib-pairs of autopsy-confirmed progressive supranuclear palsy.

  2015cited by this paper
• Hook Proteins: Association with Alzheimer Pathology and Regulatory Role of Hook3 in Amyloid Beta Generation

  2015cited by this paper
• Intraneuronal accumulation of misfolded tau protein induces overexpression of Hsp27 in activated astrocytes.

  2015cited by this paper
• Tau post-translational modifications in wildtype and human amyloid precursor protein transgenic mice

  2015cited by this paper
• The Human Tau Interactome: Binding to the Ribonucleoproteome, and Impaired Binding of the Proline-to-Leucine Mutant at Position 301 (P301L) to Chaperones and the Proteasome*

  2015cited by this paper
• Structural Impact of Tau Phosphorylation at Threonine 231.

  2015cited by this paper
• Distinct tau prion strains propagate in cells and mice and define different tauopathies.

  2014cited by this paper
• Aberrant Expression of RCAN1 in Alzheimer’s Pathogenesis: A New Molecular Mechanism and a Novel Drug Target

  2014cited by this paper
• The Co-Occurrence of Alzheimer's Disease and Huntington's Disease: A Neuropathological Study of 15 Elderly Huntington's Disease Subjects

  2014cited by this paper
• Tau protein mutation P364S in two sisters: clinical course and neuropathology with emphasis on new, composite neuronal tau inclusions

  2014cited by this paper
• Ischemia in Tumors Induces Early and Sustained Phosphorylation Changes in Stress Kinase Pathways but Does Not Affect Global Protein Levels*

  2014cited by this paper
• Microtubule-associated protein tau is essential for long-term depression in the hippocampus

  2014cited by this paper
• Huntington's disease is a four-repeat tauopathy with tau nuclear rods

  2014cited by this paper
• PhosphoSitePlus, 2014: mutations, PTMs and recalibrations

  2014cited by this paper
• Highly potent soluble amyloid-β seeds in human Alzheimer brain but not cerebrospinal fluid.

  2014cited by this paper
• A major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions

  2014cited by this paper
• Chronic traumatic encephalopathy: a spectrum of neuropathological changes following repetitive brain trauma in athletes and military personnel

  2014cited by this paper
• Biomarkers of Alzheimer’s Disease Risk in Peripheral Tissues; Focus on Buccal Cells

  2014cited by this paper
• Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases

  2014cited by this paper
• Activity-Dependent Tau Protein Translocation to Excitatory Synapse Is Disrupted by Exposure to Amyloid-Beta Oligomers

  2014cited by this paper
• Inhibition of HDAC6 Modifies Tau Inclusion Body Formation and Impairs Autophagic Clearance

  2014cited by this paper

• Global brain activity links subcortical degeneration to cortical tau progressively across Braak regions over early Alzheimer’s disease stages

  2026cites this paper
• Impact of Tau overexpression on DNA replication dynamics in centromeres of human neural progenitor cells

  2026cites this paper
• GASDERMIN D-mediated pyroptosis as a therapeutic target in TAU-dependent frontotemporal dementia mouse model

  2026cites this paper
• Insulin Signaling in Alzheimer’s Disease: Association with Brain Insulin Resistance

  2026cites this paper
• Quantitatively controlled and measured-traumatic brain injury impairs adult neurogenesis and alters neuropathological signatures in mice

  2026cites this paper
• Hyperphosphorylated tau and amyloid-β proteinopathy in people over age 50: Findings from the Lieber Institute for Brain Development Brain Donation Repository

  2026cites this paper
• Spatiotemporal transcriptomic profiling reveals upregulation of glycolysis pathway genes before overt tauopathy in the PS19 mouse model.

  2026cites this paper
• Deep Learning-Based Classification of Temporal Stages of AT8-Labeled Tau Pathology After Experimental Traumatic Brain Injury

  2026influential citation
• O-GlcNAc modification differentially regulates microtubule binding and pathological conformations of tau isoforms in vitro

  2025cites this paper
• Cross-linking mass spectrometry for structure analysis of the intrinsically disordered Tau and phosphorylated Tau protein

  2025cites this paper
• Fast and Accurate Comparison of Protein Conformational Ensembles

  2025cites this paper
• Alzheimer’s disease basics: we all should know

  2025cites this paper
• Tau post-translational modifications in Alzheimer's disease: insights into pathogenesis, therapeutic strategies, and diagnostic advances

  2025cites this paper
• Porphyromonas gingivalis outer membrane vesicles alter cortical neurons and Tau phosphorylation in the embryonic mouse brain

  2025cites this paper
• Spatiotemporal Dynamic Monitoring of Protein Conformation Changes by Super-resolution Imaging

  2025cites this paper
• VacQuant: a tool to quantify neurodegeneration and associated vacuolation in brain tissue

  2025cites this paper
• Human Glucose Transporters in Health and Selected Neurodegenerative Diseases

  2025cites this paper
• A Pilot Study on Blood Concentration of β-Amyloid (40 and 42) and Phospho-Tau 181 in Horses

  2025cites this paper
• Assessing mitochondrial number and morphology in a C. elegans model of human tauopathy.

  2025cites this paper
• Upregulating ANKHD1 in PS19 Mice Reduces Tau Phosphorylation and Mitigates Tau Toxicity-Induced Cognitive Deficits

  2025cites this paper
• BioID2-Based Tau Interactome Reveals Novel and Known Protein Interactions Associated with Multiple Cellular Pathways

  2025cites this paper
• Impact of sex and glial tau expression on heat shock protein induction in a Drosophila model of tauopathy

  2025cites this paper
• Beyond Estrogen: Unraveling the Complexities of Hormonal Signaling Pathways in Alzheimer’s Disease and Their Implications for Precision Therapy

  2025cites this paper
• Illuminating Tau Aggregates: Multiscale Approaches for Detection, Imaging, and Understanding

  2025cites this paper
• Impact of Sex and Glial Tau Expression on Heat Shock Protein Induction in a Drosophila Model of Tauopathy

  2025cites this paper
• Spatiotemporal transcriptomic profiling reveals metabolic dysfunction prior to overt tauopathy in the PS19 mouse model

  2025cites this paper
• Bibliometric analysis of neural injury biomarkers in neurodegenerative diseases: research trends and future perspectives

  2025cites this paper
• Comprehensive Review of Acer truncatum Seed Oil: Sustainable Extraction Technologies, Unique Bioactive Profile, and Emerging Applications

  2025cites this paper
• Redox signaling modulates axonal microtubule organization and induces a specific phosphorylation signature of microtubule-regulating proteins

  2025cites this paper
• Pathogenic Oligomeric Tau alters Neuronal RNA Processes through the Formation of Nuclear Heteromeric Amyloids with RNA-Binding Protein Musashi1.

  2025cites this paper
• In vivo quantification of [11C]BIO-1819578 in non-human primates, a novel radioligand for O-GlcNAcase

  2025cites this paper
• A Multivariable Mathematical Model of Conductivity, β-Amyloid and T-Protein Dynamics in Alzheimer’s Disease Progression

  2025cites this paper
• Environmental enrichment attenuates sevoflurane anesthesia-induced learning deficits in aged mice through regulating TTBK1 and phosphorylated Tau expression

  2025cites this paper
• RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection

  2025cites this paper
• Inhaled Lead Nanoparticles Enter the Brain through the Olfactory Pathway and Induce Neurodegenerative Changes Resembling Tauopathies.

  2025cites this paper
• Application of modular isoxazoline-β2,2-amino acid-based peptidomimetics as chemical model systems for studying the tau misfolding

  2025cites this paper
• Selective imaging probes for differential detection of pathological tau polymorphs in tauopathies.

  2025cites this paper
• Proximity Labeling of the Tau Repeat Domain Enriches RNA-Binding Proteins That Are Altered in Alzheimer's Disease and Related Tauopathies

  2025cites this paper
• Phase transition of WTAP regulates m6A modification of interferon-stimulated genes

  2025cites this paper
• A Mathematical Model for the Variation of Cerebral Electrical Conductivity and the Amount of β-Amyloid Protein Values Due to Alzheimer’s Disease

  2025cites this paper
• Glial Cells in Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Frontiers

  2025cites this paper
• Tau Protein Disrupts Mitochondrial Homeostasis in a Yeast Model: Implications for Alzheimer’s Disease

  2025cites this paper
• Tauopathies: Calmodulin Regulates Tau Hyperphosphorylation and Its Transformation into Disease-Specific Aggregates

  2025cites this paper
• Lysine-Targeting Inhibitors of Amyloidogenic Protein Aggregation: A Promise for Neurodegenerative Proteinopathies

  2025cites this paper
• The N-terminal domain of COMPANION OF CELLULOSE SYNTHASE1 promotes microtubule array formation in Arabidopsis.

  2025cites this paper
• Tau Axonal Sorting and Interaction With Synaptic Plasticity Modulators Is Domain‐ and Isoform‐Dependent in Human iPSC‐Derived Neurons

  2025influential citation
• Brain-derived tau oligomer polymorphs: distinct aggregations, stability profiles, and biological activities

  2025cites this paper
• Mechanical stimulation prevents impairment of axon growth and overcompensates microtubule destabilization in cellular models of Alzheimer’s disease and related Tau pathologies

  2025cites this paper
• Homer-3 antibody in autoimmune cerebellar syndromes: a potentially treatable mimic of MSA-C – A review

  2025influential citation
• Precise ligand-selective mechanism at the fab domain of a tau-recognizing antibody.

  2025cites this paper
• Temporal Interactome Mapping of Human Tau in Drosophila Reveals Progressive Mitochondrial Engagement and Porin/VDAC1-Dependent Modulation of Toxicity

  2025cites this paper
• Bioelectronic Interfaces and Sensors for Neural Organoids

  2025cites this paper
• FibrilPaint to determine the length of Tau amyloids in fluids

  2025cites this paper
• Reversible tau hyperphosphorylation in hibernation: a blood biomarker and brain tissue study

  2025influential citation
• Preclinical Development of a Vectorized Artificial miRNA Gene Therapy for Tauopathies

  2025cites this paper
• Diabetes-linked metabolic dysfunction relates with distinct tau phosphorylation patterns, neuroinflammation and cognitive impairment in mouse models of Alzheimer's disease.

  2025cites this paper
• Preclinical and Prodromal Frontotemporal Dementia: Challenges and Opportunities

  2025cites this paper
• Neurons ensheathed by perineuronal nets are prone to hyperphosphorylation of tau protein in the hibernating Syrian hamster brain

  2025cites this paper
• Current understanding of the microscopic effects of intrinsically disordered protein aggregates on the interfacial solvent properties

  2025cites this paper
• Blood biomarkers for clinical applications in Alzheimer's disease: A narrative review

  2025cites this paper
• Convergent Assembly of Homo‐ and Heterotypic Ubiquitin Chains from Functionalized, Expressed Monomers via Thiol‐Ene Chemistry

  2025cites this paper
• Probe-dependent Proximity Profiling (ProPPr) Uncovers Similarities and Differences in Phospho-Tau-Associated Proteomes Between Tauopathies

  2025cites this paper
• Towards mechanism-based tau-targeted therapies

  2025cites this paper
• ANXA2 Protein and Its Role in Neurodegeneration Processes

  2025cites this paper
• Chlorophyll-Based Optogenetics to Control Membraneless Organelles.

  2025cites this paper
• Associations Between Diabetes Mellitus and Neurodegenerative Diseases

  2025cites this paper
• Structural insights into the role of the proline rich region in tau function.

  2025cites this paper
• Proximity labeling of the Tau repeat domain enriches RNA-binding proteins that are altered in Alzheimer’s disease and related tauopathies

  2025cites this paper
• Upregulating ANKHD1 in PS19 mice reduces Tau phosphorylation and mitigates Tau-toxicity-induced cognitive deficits

  2024cites this paper
• Brain aging and Alzheimer’s disease, a perspective from non-human primates

  2024cites this paper
• Cerebral hypoperfusion reduces tau accumulation

  2024cites this paper
• Molecular Interactions between Tau Protein and TIA1: Distinguishing Physiological Condensates from Pathological Fibrils.

  2024cites this paper
• Pathogenic Mutation ΔK280 Promotes Hydrophobic Interactions Involving Microtubule-Binding Domain and Enhances Liquid-Liquid Phase Separation of Tau.

  2024cites this paper
• Control Intracellular Protein Condensates with Light.

  2024cites this paper
• Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer’s Disease

  2024cites this paper
• From circadian sleep disruption to Neuroprotection: The potential of VIP/PACAP in Alzheimer’s disease treatment

  2024cites this paper
• MAD—microbial (origin of) Alzheimer’s disease hypothesis: from infection and the antimicrobial response to disruption of key copper-based systems

  2024cites this paper
• Exploring Intrinsic Disorder in Human Synucleins and Associated Proteins

  2024cites this paper
• Targeting RNA with small molecules, from RNA structures to precision medicines: IUPHAR review: 40

  2024influential citation
• Novel targets for the treatment and prevention of Alzheimer's disease in the European population, inspiration from amyloid beta and tau protein

  2024cites this paper
• Serum Tau Species in Progressive Supranuclear Palsy: A Pilot Study

  2024cites this paper
• Structural basis of binding the unique N-terminal domain of microtubule-associated protein 2c to proteins regulating kinases of signaling pathways

  2024cites this paper
• Nesfatin-1 ameliorates pathological abnormalities in Drosophila hTau model of Alzheimer's disease.

  2024cites this paper
• Effects of P301L-TAU on post-translational modifications of microtubules in human iPSC-derived cortical neurons and TAU transgenic mice

  2024cites this paper
• Tau protein profiling in tauopathies: a human brain study

  2024cites this paper
• Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry

  2024cites this paper
• Retracted Article: The interaction between insulin resistance and Alzheimer’s disease: a review article

  2024cites this paper
• Construction of a cell-based aggregation and seeding model for the Tau protein

  2024cites this paper
• Tau, Glial Fibrillary Acidic Protein, and Neurofilament Light Chain as Brain Protein Biomarkers in Cerebrospinal Fluid and Blood for Diagnosis of Neurobiological Diseases

  2024cites this paper
• Characterization and Expression of the Microtubule Associated Protein Tau Gene Isoforms and their Impact on Clinical Outcomes in Glioma Patients

  2024cites this paper
• Alzheimer’s Disease Neuropathological Change in Aged Non-Primate Mammals

  2024cites this paper
• The Search for a Universal Treatment for Defined and Mixed Pathology Neurodegenerative Diseases

  2024cites this paper
• Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration

  2024cites this paper
• Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies

  2024influential citation
• Preparation of Tau Condensates by Liquid-Liquid Phase Separation to Study Tau Amyloid Aggregation.

  2024cites this paper
• Differentiating SH-SY5Y Cells into Polarized Human Neurons for Studying Endogenous and Exogenous Tau Trafficking: Four Protocols to Obtain Neurons with Noradrenergic, Dopaminergic, and Cholinergic Properties.

  2024cites this paper
• [Specific modifications of the soluble tau protein distinguish Alzheimer's disease from other tauopathies].

  2024cites this paper
• Choline Metabolites Reverse Differentially the Habituation Deficit and Elevated Memory of Tau Null Drosophila

  2024cites this paper
• Mathematical topology and geometry-based classification of tauopathies

  2024cites this paper
• The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes

  2024cites this paper